Pyrophosphate Stimulates Wild-type and Mutant Cystic Fibrosis Transmembrane Conductance Regulator Cl− Channels (∗)

A unique feature of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl− channel is regulation by ATP through the two cytoplasmic nucleotide-binding domains (NBDs). To better understand this process, we asked how channel activity is affected by inorganic pyrophosphate (PPi), a compound...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of biological chemistry 1995-09, Vol.270 (35), p.20466-20472
Hauptverfasser: Carson, Mark R., Winter, Michael C., Travis, Sue M., Welsh, Michael J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 20472
container_issue 35
container_start_page 20466
container_title The Journal of biological chemistry
container_volume 270
creator Carson, Mark R.
Winter, Michael C.
Travis, Sue M.
Welsh, Michael J.
description A unique feature of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl− channel is regulation by ATP through the two cytoplasmic nucleotide-binding domains (NBDs). To better understand this process, we asked how channel activity is affected by inorganic pyrophosphate (PPi), a compound that binds to NBDs in other proteins. PPi and three nonhydrolyzable PPi analogs reversibly stimulated the activity of phosphorylated channels. Kinetic modeling of single channel data demonstrated that PPi affected two distinct steps in channel regulation. First, PPi increased the rate at which channels opened. Second, once channels were open, PPi delayed their closure. PPi could only stimulate channels when it was applied in the presence of ATP. PPi also increased the photolabeling of CFTR by an ATP analog. These two findings suggest that PPi modifies the activity of ATP-dependent CFTR channel gating. Based on these and previous data, we speculate that the effects of PPi are mediated by binding of PPi to NBD2 where it regulates channel opening by NBD1, and then, because it is not hydrolyzed, it slows the rate of NBD2-mediated channel closing. Because PPi stimulated wild-type channels, we tested its effect on CFTR containing the cystic fibrosis mutations: ΔF508, R117H, and G551S. PPi stimulated all three. PPi also stimulated endogenous CFTR in the apical membrane of permeabilized T-84 epithelia. These results suggest that PPi or an analog might be of value in the development of new approaches to the treatment of cystic fibrosis.
doi_str_mv 10.1074/jbc.270.35.20466
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77490403</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021925818904084</els_id><sourcerecordid>77490403</sourcerecordid><originalsourceid>FETCH-LOGICAL-c482t-dd336f75eca71908154407807628d06703b45423c8baceede92413b39d12b1213</originalsourceid><addsrcrecordid>eNp1kM1u1DAUhS1EVYbCng2SFwjBIoP_EjvdoYgCUqsiKIKdldh3GldJHGynaN6gaza8X58EtzNigYQ319I95-jcD6FnlKwpkeLNVWfWTJI1L9eMiKp6gFaUKF7wkn5_iFaEMFrUrFSP0OMYr0h-oqaH6FCWQkilVuj60zb4ufdx7tsE-Ety4zLkX8Tf3GCLtJ0Bt5PFZ0tqp4SbbUzO4BPXBR9dxBehneIIY5cn4MZPdjFZaAB_hsu7IB9wM9ze_MJN304TDBG_ur35_foJOti0Q4Sn-3mEvp68u2g-FKfn7z82b08LIxRLhbWcVxtZgmklrYmiuTaRisiKKUsqSXgnSsG4UV1rACzUTFDe8dpS1lFG-RF6ucudg_-xQEx6dNHAMOS6folaSlETQXgWkp3Q5MNigI2egxvbsNWU6DvUOqPWGbXmpb5HnS3P99lLN4L9a9izzfsXu33vLvufLoDunDc9jP_GHO9kGQ5cOwg6GgcZoc0Wk7T17v8d_gDMopuW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77490403</pqid></control><display><type>article</type><title>Pyrophosphate Stimulates Wild-type and Mutant Cystic Fibrosis Transmembrane Conductance Regulator Cl− Channels (∗)</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Carson, Mark R. ; Winter, Michael C. ; Travis, Sue M. ; Welsh, Michael J.</creator><creatorcontrib>Carson, Mark R. ; Winter, Michael C. ; Travis, Sue M. ; Welsh, Michael J.</creatorcontrib><description>A unique feature of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl− channel is regulation by ATP through the two cytoplasmic nucleotide-binding domains (NBDs). To better understand this process, we asked how channel activity is affected by inorganic pyrophosphate (PPi), a compound that binds to NBDs in other proteins. PPi and three nonhydrolyzable PPi analogs reversibly stimulated the activity of phosphorylated channels. Kinetic modeling of single channel data demonstrated that PPi affected two distinct steps in channel regulation. First, PPi increased the rate at which channels opened. Second, once channels were open, PPi delayed their closure. PPi could only stimulate channels when it was applied in the presence of ATP. PPi also increased the photolabeling of CFTR by an ATP analog. These two findings suggest that PPi modifies the activity of ATP-dependent CFTR channel gating. Based on these and previous data, we speculate that the effects of PPi are mediated by binding of PPi to NBD2 where it regulates channel opening by NBD1, and then, because it is not hydrolyzed, it slows the rate of NBD2-mediated channel closing. Because PPi stimulated wild-type channels, we tested its effect on CFTR containing the cystic fibrosis mutations: ΔF508, R117H, and G551S. PPi stimulated all three. PPi also stimulated endogenous CFTR in the apical membrane of permeabilized T-84 epithelia. These results suggest that PPi or an analog might be of value in the development of new approaches to the treatment of cystic fibrosis.</description><identifier>ISSN: 0021-9258</identifier><identifier>EISSN: 1083-351X</identifier><identifier>DOI: 10.1074/jbc.270.35.20466</identifier><identifier>PMID: 7544788</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adenosine Triphosphate - pharmacology ; Animals ; Cell Line ; Cell Membrane - physiology ; Chloride Channels - drug effects ; Chloride Channels - physiology ; Cyclic AMP - pharmacology ; Cyclic AMP-Dependent Protein Kinases - pharmacology ; Cystic Fibrosis - genetics ; Cystic Fibrosis Transmembrane Conductance Regulator ; Diphosphates - pharmacology ; Epithelium - physiology ; Etidronic Acid - pharmacology ; HeLa Cells ; Humans ; Kinetics ; Mammary Glands, Animal ; Membrane Potentials - drug effects ; Membrane Potentials - physiology ; Membrane Proteins - drug effects ; Membrane Proteins - genetics ; Membrane Proteins - physiology ; Mice ; Patch-Clamp Techniques ; Point Mutation ; Recombinant Proteins - biosynthesis ; Recombinant Proteins - drug effects ; Recombinant Proteins - metabolism ; Transfection</subject><ispartof>The Journal of biological chemistry, 1995-09, Vol.270 (35), p.20466-20472</ispartof><rights>1995 © 1995 ASBMB. Currently published by Elsevier Inc; originally published by American Society for Biochemistry and Molecular Biology.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c482t-dd336f75eca71908154407807628d06703b45423c8baceede92413b39d12b1213</citedby><cites>FETCH-LOGICAL-c482t-dd336f75eca71908154407807628d06703b45423c8baceede92413b39d12b1213</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7544788$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carson, Mark R.</creatorcontrib><creatorcontrib>Winter, Michael C.</creatorcontrib><creatorcontrib>Travis, Sue M.</creatorcontrib><creatorcontrib>Welsh, Michael J.</creatorcontrib><title>Pyrophosphate Stimulates Wild-type and Mutant Cystic Fibrosis Transmembrane Conductance Regulator Cl− Channels (∗)</title><title>The Journal of biological chemistry</title><addtitle>J Biol Chem</addtitle><description>A unique feature of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl− channel is regulation by ATP through the two cytoplasmic nucleotide-binding domains (NBDs). To better understand this process, we asked how channel activity is affected by inorganic pyrophosphate (PPi), a compound that binds to NBDs in other proteins. PPi and three nonhydrolyzable PPi analogs reversibly stimulated the activity of phosphorylated channels. Kinetic modeling of single channel data demonstrated that PPi affected two distinct steps in channel regulation. First, PPi increased the rate at which channels opened. Second, once channels were open, PPi delayed their closure. PPi could only stimulate channels when it was applied in the presence of ATP. PPi also increased the photolabeling of CFTR by an ATP analog. These two findings suggest that PPi modifies the activity of ATP-dependent CFTR channel gating. Based on these and previous data, we speculate that the effects of PPi are mediated by binding of PPi to NBD2 where it regulates channel opening by NBD1, and then, because it is not hydrolyzed, it slows the rate of NBD2-mediated channel closing. Because PPi stimulated wild-type channels, we tested its effect on CFTR containing the cystic fibrosis mutations: ΔF508, R117H, and G551S. PPi stimulated all three. PPi also stimulated endogenous CFTR in the apical membrane of permeabilized T-84 epithelia. These results suggest that PPi or an analog might be of value in the development of new approaches to the treatment of cystic fibrosis.</description><subject>Adenosine Triphosphate - pharmacology</subject><subject>Animals</subject><subject>Cell Line</subject><subject>Cell Membrane - physiology</subject><subject>Chloride Channels - drug effects</subject><subject>Chloride Channels - physiology</subject><subject>Cyclic AMP - pharmacology</subject><subject>Cyclic AMP-Dependent Protein Kinases - pharmacology</subject><subject>Cystic Fibrosis - genetics</subject><subject>Cystic Fibrosis Transmembrane Conductance Regulator</subject><subject>Diphosphates - pharmacology</subject><subject>Epithelium - physiology</subject><subject>Etidronic Acid - pharmacology</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Mammary Glands, Animal</subject><subject>Membrane Potentials - drug effects</subject><subject>Membrane Potentials - physiology</subject><subject>Membrane Proteins - drug effects</subject><subject>Membrane Proteins - genetics</subject><subject>Membrane Proteins - physiology</subject><subject>Mice</subject><subject>Patch-Clamp Techniques</subject><subject>Point Mutation</subject><subject>Recombinant Proteins - biosynthesis</subject><subject>Recombinant Proteins - drug effects</subject><subject>Recombinant Proteins - metabolism</subject><subject>Transfection</subject><issn>0021-9258</issn><issn>1083-351X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kM1u1DAUhS1EVYbCng2SFwjBIoP_EjvdoYgCUqsiKIKdldh3GldJHGynaN6gaza8X58EtzNigYQ319I95-jcD6FnlKwpkeLNVWfWTJI1L9eMiKp6gFaUKF7wkn5_iFaEMFrUrFSP0OMYr0h-oqaH6FCWQkilVuj60zb4ufdx7tsE-Ety4zLkX8Tf3GCLtJ0Bt5PFZ0tqp4SbbUzO4BPXBR9dxBehneIIY5cn4MZPdjFZaAB_hsu7IB9wM9ze_MJN304TDBG_ur35_foJOti0Q4Sn-3mEvp68u2g-FKfn7z82b08LIxRLhbWcVxtZgmklrYmiuTaRisiKKUsqSXgnSsG4UV1rACzUTFDe8dpS1lFG-RF6ucudg_-xQEx6dNHAMOS6folaSlETQXgWkp3Q5MNigI2egxvbsNWU6DvUOqPWGbXmpb5HnS3P99lLN4L9a9izzfsXu33vLvufLoDunDc9jP_GHO9kGQ5cOwg6GgcZoc0Wk7T17v8d_gDMopuW</recordid><startdate>19950901</startdate><enddate>19950901</enddate><creator>Carson, Mark R.</creator><creator>Winter, Michael C.</creator><creator>Travis, Sue M.</creator><creator>Welsh, Michael J.</creator><general>Elsevier Inc</general><general>American Society for Biochemistry and Molecular Biology</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19950901</creationdate><title>Pyrophosphate Stimulates Wild-type and Mutant Cystic Fibrosis Transmembrane Conductance Regulator Cl− Channels (∗)</title><author>Carson, Mark R. ; Winter, Michael C. ; Travis, Sue M. ; Welsh, Michael J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c482t-dd336f75eca71908154407807628d06703b45423c8baceede92413b39d12b1213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>Adenosine Triphosphate - pharmacology</topic><topic>Animals</topic><topic>Cell Line</topic><topic>Cell Membrane - physiology</topic><topic>Chloride Channels - drug effects</topic><topic>Chloride Channels - physiology</topic><topic>Cyclic AMP - pharmacology</topic><topic>Cyclic AMP-Dependent Protein Kinases - pharmacology</topic><topic>Cystic Fibrosis - genetics</topic><topic>Cystic Fibrosis Transmembrane Conductance Regulator</topic><topic>Diphosphates - pharmacology</topic><topic>Epithelium - physiology</topic><topic>Etidronic Acid - pharmacology</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Mammary Glands, Animal</topic><topic>Membrane Potentials - drug effects</topic><topic>Membrane Potentials - physiology</topic><topic>Membrane Proteins - drug effects</topic><topic>Membrane Proteins - genetics</topic><topic>Membrane Proteins - physiology</topic><topic>Mice</topic><topic>Patch-Clamp Techniques</topic><topic>Point Mutation</topic><topic>Recombinant Proteins - biosynthesis</topic><topic>Recombinant Proteins - drug effects</topic><topic>Recombinant Proteins - metabolism</topic><topic>Transfection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carson, Mark R.</creatorcontrib><creatorcontrib>Winter, Michael C.</creatorcontrib><creatorcontrib>Travis, Sue M.</creatorcontrib><creatorcontrib>Welsh, Michael J.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of biological chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carson, Mark R.</au><au>Winter, Michael C.</au><au>Travis, Sue M.</au><au>Welsh, Michael J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pyrophosphate Stimulates Wild-type and Mutant Cystic Fibrosis Transmembrane Conductance Regulator Cl− Channels (∗)</atitle><jtitle>The Journal of biological chemistry</jtitle><addtitle>J Biol Chem</addtitle><date>1995-09-01</date><risdate>1995</risdate><volume>270</volume><issue>35</issue><spage>20466</spage><epage>20472</epage><pages>20466-20472</pages><issn>0021-9258</issn><eissn>1083-351X</eissn><abstract>A unique feature of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl− channel is regulation by ATP through the two cytoplasmic nucleotide-binding domains (NBDs). To better understand this process, we asked how channel activity is affected by inorganic pyrophosphate (PPi), a compound that binds to NBDs in other proteins. PPi and three nonhydrolyzable PPi analogs reversibly stimulated the activity of phosphorylated channels. Kinetic modeling of single channel data demonstrated that PPi affected two distinct steps in channel regulation. First, PPi increased the rate at which channels opened. Second, once channels were open, PPi delayed their closure. PPi could only stimulate channels when it was applied in the presence of ATP. PPi also increased the photolabeling of CFTR by an ATP analog. These two findings suggest that PPi modifies the activity of ATP-dependent CFTR channel gating. Based on these and previous data, we speculate that the effects of PPi are mediated by binding of PPi to NBD2 where it regulates channel opening by NBD1, and then, because it is not hydrolyzed, it slows the rate of NBD2-mediated channel closing. Because PPi stimulated wild-type channels, we tested its effect on CFTR containing the cystic fibrosis mutations: ΔF508, R117H, and G551S. PPi stimulated all three. PPi also stimulated endogenous CFTR in the apical membrane of permeabilized T-84 epithelia. These results suggest that PPi or an analog might be of value in the development of new approaches to the treatment of cystic fibrosis.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>7544788</pmid><doi>10.1074/jbc.270.35.20466</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0021-9258
ispartof The Journal of biological chemistry, 1995-09, Vol.270 (35), p.20466-20472
issn 0021-9258
1083-351X
language eng
recordid cdi_proquest_miscellaneous_77490403
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adenosine Triphosphate - pharmacology
Animals
Cell Line
Cell Membrane - physiology
Chloride Channels - drug effects
Chloride Channels - physiology
Cyclic AMP - pharmacology
Cyclic AMP-Dependent Protein Kinases - pharmacology
Cystic Fibrosis - genetics
Cystic Fibrosis Transmembrane Conductance Regulator
Diphosphates - pharmacology
Epithelium - physiology
Etidronic Acid - pharmacology
HeLa Cells
Humans
Kinetics
Mammary Glands, Animal
Membrane Potentials - drug effects
Membrane Potentials - physiology
Membrane Proteins - drug effects
Membrane Proteins - genetics
Membrane Proteins - physiology
Mice
Patch-Clamp Techniques
Point Mutation
Recombinant Proteins - biosynthesis
Recombinant Proteins - drug effects
Recombinant Proteins - metabolism
Transfection
title Pyrophosphate Stimulates Wild-type and Mutant Cystic Fibrosis Transmembrane Conductance Regulator Cl− Channels (∗)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T21%3A33%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pyrophosphate%20Stimulates%20Wild-type%20and%20Mutant%20Cystic%20Fibrosis%20Transmembrane%20Conductance%20Regulator%20Cl%E2%88%92%20Channels%20(%E2%88%97)&rft.jtitle=The%20Journal%20of%20biological%20chemistry&rft.au=Carson,%20Mark%20R.&rft.date=1995-09-01&rft.volume=270&rft.issue=35&rft.spage=20466&rft.epage=20472&rft.pages=20466-20472&rft.issn=0021-9258&rft.eissn=1083-351X&rft_id=info:doi/10.1074/jbc.270.35.20466&rft_dat=%3Cproquest_cross%3E77490403%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77490403&rft_id=info:pmid/7544788&rft_els_id=S0021925818904084&rfr_iscdi=true